Cargando…
The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome
OBJECTIVE: The role of the hydroxycarboxylic acid receptor 2 (HCA(2)) in the retinal damage induced by diabetes has never been explored. In this context, the present study highlights an upregulation of retinal HCA(2) receptors in diabetic C57BL6J mice. Moreover, we illustrate that HCA(2) receptors e...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338370/ https://www.ncbi.nlm.nih.gov/pubmed/30657794 http://dx.doi.org/10.1371/journal.pone.0211005 |
_version_ | 1783388440984813568 |
---|---|
author | Trotta, Maria Consiglia Maisto, Rosa Guida, Francesca Boccella, Serena Luongo, Livio Balta, Cornel D’Amico, Giovanbattista Herman, Hildegard Hermenean, Anca Bucolo, Claudio D’Amico, Michele |
author_facet | Trotta, Maria Consiglia Maisto, Rosa Guida, Francesca Boccella, Serena Luongo, Livio Balta, Cornel D’Amico, Giovanbattista Herman, Hildegard Hermenean, Anca Bucolo, Claudio D’Amico, Michele |
author_sort | Trotta, Maria Consiglia |
collection | PubMed |
description | OBJECTIVE: The role of the hydroxycarboxylic acid receptor 2 (HCA(2)) in the retinal damage induced by diabetes has never been explored. In this context, the present study highlights an upregulation of retinal HCA(2) receptors in diabetic C57BL6J mice. Moreover, we illustrate that HCA(2) receptors exert an anti-inflammatory effect on the retinal damage induced by diabetes when activated by the endogenous ligand β-hydroxybutyrate, METHODOLOGY: Seven-to-10-week-old C57BL6J mice were rendered diabetic by a single intraperitoneal injection of streptozotocin (75 mg/kg of body weight) and monitored intermittently over a 10-week period extending from the initial diabetes assessment. Mice with a fasting blood glucose level higher than 250 mg/dl for 2 consecutive weeks after streptozotocin injection were treated twice a week with intraperitoneal injections of 25-50-100 mg/kg β-hydroxybutyrate. RESULTS: Interestingly, while the retinal endoplasmic reticulum stress markers (pPERK, pIRE1, ATF-6α) were elevated in diabetic C57BL6J mice, their levels were significantly reduced by the systemic intraperitoneal treatment with 50 mg/kg and 100 mg/kg β-hydroxybutyrate. These mice also exhibited high NLRP3 inflammasome activity and proinflammatory cytokine levels. In fact, the elevated levels of retinal NLRP3 inflammasome activation markers (NLRP3, ASC, caspase-1) and of the relative proinflammatory cytokines (IL-1β, IL-18) were significantly reduced by 50 mg/kg and 100 mg/kg β-hydroxybutyrate treatment. These doses also reduced the high apoptotic cell number exhibited by the diabetic mice in the retinal outer nuclear layer (ONL) and increased the ONL low connexin 43 expression, leading to an improvement in retinal permeability and homeostasis. CONCLUSIONS: These data suggest that the systemic treatment of diabetic C57BL6J mice with BHB activates retinal HCA(2) and inhibits local damage. |
format | Online Article Text |
id | pubmed-6338370 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-63383702019-01-30 The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome Trotta, Maria Consiglia Maisto, Rosa Guida, Francesca Boccella, Serena Luongo, Livio Balta, Cornel D’Amico, Giovanbattista Herman, Hildegard Hermenean, Anca Bucolo, Claudio D’Amico, Michele PLoS One Research Article OBJECTIVE: The role of the hydroxycarboxylic acid receptor 2 (HCA(2)) in the retinal damage induced by diabetes has never been explored. In this context, the present study highlights an upregulation of retinal HCA(2) receptors in diabetic C57BL6J mice. Moreover, we illustrate that HCA(2) receptors exert an anti-inflammatory effect on the retinal damage induced by diabetes when activated by the endogenous ligand β-hydroxybutyrate, METHODOLOGY: Seven-to-10-week-old C57BL6J mice were rendered diabetic by a single intraperitoneal injection of streptozotocin (75 mg/kg of body weight) and monitored intermittently over a 10-week period extending from the initial diabetes assessment. Mice with a fasting blood glucose level higher than 250 mg/dl for 2 consecutive weeks after streptozotocin injection were treated twice a week with intraperitoneal injections of 25-50-100 mg/kg β-hydroxybutyrate. RESULTS: Interestingly, while the retinal endoplasmic reticulum stress markers (pPERK, pIRE1, ATF-6α) were elevated in diabetic C57BL6J mice, their levels were significantly reduced by the systemic intraperitoneal treatment with 50 mg/kg and 100 mg/kg β-hydroxybutyrate. These mice also exhibited high NLRP3 inflammasome activity and proinflammatory cytokine levels. In fact, the elevated levels of retinal NLRP3 inflammasome activation markers (NLRP3, ASC, caspase-1) and of the relative proinflammatory cytokines (IL-1β, IL-18) were significantly reduced by 50 mg/kg and 100 mg/kg β-hydroxybutyrate treatment. These doses also reduced the high apoptotic cell number exhibited by the diabetic mice in the retinal outer nuclear layer (ONL) and increased the ONL low connexin 43 expression, leading to an improvement in retinal permeability and homeostasis. CONCLUSIONS: These data suggest that the systemic treatment of diabetic C57BL6J mice with BHB activates retinal HCA(2) and inhibits local damage. Public Library of Science 2019-01-18 /pmc/articles/PMC6338370/ /pubmed/30657794 http://dx.doi.org/10.1371/journal.pone.0211005 Text en © 2019 Trotta et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Trotta, Maria Consiglia Maisto, Rosa Guida, Francesca Boccella, Serena Luongo, Livio Balta, Cornel D’Amico, Giovanbattista Herman, Hildegard Hermenean, Anca Bucolo, Claudio D’Amico, Michele The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome |
title | The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome |
title_full | The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome |
title_fullStr | The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome |
title_full_unstemmed | The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome |
title_short | The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome |
title_sort | activation of retinal hca2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the nlrp3 inflammasome |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338370/ https://www.ncbi.nlm.nih.gov/pubmed/30657794 http://dx.doi.org/10.1371/journal.pone.0211005 |
work_keys_str_mv | AT trottamariaconsiglia theactivationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome AT maistorosa theactivationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome AT guidafrancesca theactivationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome AT boccellaserena theactivationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome AT luongolivio theactivationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome AT baltacornel theactivationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome AT damicogiovanbattista theactivationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome AT hermanhildegard theactivationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome AT hermeneananca theactivationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome AT bucoloclaudio theactivationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome AT damicomichele theactivationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome AT trottamariaconsiglia activationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome AT maistorosa activationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome AT guidafrancesca activationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome AT boccellaserena activationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome AT luongolivio activationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome AT baltacornel activationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome AT damicogiovanbattista activationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome AT hermanhildegard activationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome AT hermeneananca activationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome AT bucoloclaudio activationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome AT damicomichele activationofretinalhca2receptorsbysystemicbetahydroxybutyrateinhibitsdiabeticretinaldamagethroughreductionofendoplasmicreticulumstressandthenlrp3inflammasome |